Conversely, in the presence of tumor-derived cytokines, such as CXCLs and GM-CSF, the customary differentiation process of IMCs is perturbed, compelling their transition into MDSCs and subsequent expansion and activation within peripheral blood, bone marrow, or tumor lesions [39,40]. The gene discussed is CSF2; the disease is neoplasm.